Heart failure and the elderly: Disease diversity, data, and delivery of care

American Heart Journal

Volumn 146, Issue 2, 2003, Pages 194-196

  Alexander, Karen P ^a   Biswas, Mimi S ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; ELDERLY CARE; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEART FAILURE; HEMODYNAMIC MONITORING; HUMAN; PATIENT CARE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0042627993     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00190-X     Document Type: Editorial

References (18)

1. Masoudi FA, Havranek EP, Wolfe P, et al. Most hospitalized older persons do not meet the enrollment criterio for clinical trials in heart failure. Am Heart J 2003;146:250-7.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
3. MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/LX Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
4. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
5. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001;708-13.
6. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1417-22.
7. Heiat A, Gross CP, Krumholtz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002;162:1682-8.
8. Shocken DD, Arrieta MI, Leaverton PE, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
9. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons. Ann Intern Med 2002;137:631-9.
10. Peterson ED, Lytle BL, Alexander KP, et al. The willingness of under-represented groups to participate in clinical trials. J Am Coll Cardiol 2002;39:435A.
11. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-14.
12. Thackray S., Witte K., Clark AL, et al. Clinical trials update: OP-TIME-CHF, PRAISE-2, ALL-HAT. Eur J Heart Failure 2000;2:209-12.
13. Yusuf S, Lonn E, Bosch J, et al. Summary of randomized trails of angiotensin converting enzyme inhibitors. Clin Exp Hypertens 1999;21:835-45.
14. Levine TB, Levine AB, Bolenbaugh J, et al. Reversal of heart failure remodeling with age. Am J Geriat Cardiol 2002;11:299-304.
15. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002;347:1403-11.
16. Howard PA, Shireman TI, Dhingra A, et al. Patterns of ACE inhibitor use in elderly Medicaid patients with heart failure. Am J Geriat Cardiol 2002;11:287-94.
17. Al-Khadra AS, Salem DN, Rand WM, et al. Antiplatelet agents and survival: a cohort Analysis from the studies of Left Ventricular Dysfunction (SOLVD) trial. J Am Coll Cardiol 1998;31:419-25.
18. Cohn JN, Tognoni GA, for the Valsartan Heart Failure Trial Investigators. Randomized Trial of the Angiotensin-receptor blocker Valsartan in Chronic Heart Failure. N Eng J Med 2001;345:1667-75.